Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 244

1.

Risk of second primary malignancies in head and neck cancer patients treated with definitive radiotherapy.

Ng SP, Pollard C 3rd, Kamal M, Ayoub Z, Garden AS, Bahig H, Gunn GB, Frank SJ, Skinner HD, Phan J, Berends J, Morrison WH, Johnson JM, Ferrarotto R, Sturgis EM, Mohamed ASR, Lai SY, Fuller CD, Rosenthal DI.

NPJ Precis Oncol. 2019 Sep 27;3:22. doi: 10.1038/s41698-019-0097-y. eCollection 2019.

2.

Dysphagia After Primary Transoral Robotic Surgery With Neck Dissection vs Nonsurgical Therapy in Patients With Low- to Intermediate-Risk Oropharyngeal Cancer.

Hutcheson KA, Warneke CL, Yao CMKL, Zaveri J, Elgohari BE, Goepfert R, Hessel AC, Kupferman ME, Lai SY, Fuller CD, Gunn GB, Garden AS, Johnson F, Ferrarotto R, Lewin JS, Gross ND; MD Anderson Head and Neck Cancer Symptom Working Group.

JAMA Otolaryngol Head Neck Surg. 2019 Sep 26. doi: 10.1001/jamaoto.2019.2725. [Epub ahead of print]

PMID:
31556933
3.

ASCO Neck Dissection Guidelines Response Letter.

Schilling C, Lai SY, Chegini S, McGurk M.

J Oncol Pract. 2019 Oct;15(10):560-561. doi: 10.1200/JOP.19.00331. Epub 2019 Sep 12. No abstract available.

PMID:
31513477
4.

Swallowing-related outcomes associated with late lower cranial neuropathy in long-term oropharyngeal cancer survivors: cross-sectional survey analysis.

Aggarwal P, Zaveri JS, Goepfert RP, Shi Q, Du XL, Swartz M, Lai SY, Fuller CD, Lewin JS, Piller LB, Hutcheson KA.

Head Neck. 2019 Nov;41(11):3880-3894. doi: 10.1002/hed.25923. Epub 2019 Aug 23.

PMID:
31441572
5.

Chronic radiation-associated dysphagia in oropharyngeal cancer survivors: Towards age-adjusted dose constraints for deglutitive muscles.

MD Anderson Head and Neck Cancer Symptom Working Group; Spatial-Non-spatial Multi-Dimensional Analysis of Radiotherapy Treatment/Toxicity Team (SMART3).

Clin Transl Radiat Oncol. 2019 Jun 15;18:16-22. doi: 10.1016/j.ctro.2019.06.005. eCollection 2019 Sep.

6.

Complete Surgical Resection Following Neoadjuvant Dabrafenib Plus Trametinib in BRAFV600E-Mutated Anaplastic Thyroid Carcinoma.

Wang JR, Zafereo ME, Dadu R, Ferrarotto R, Busaidy NL, Lu C, Ahmed S, Gule-Monroe MK, Williams MD, Sturgis EM, Goepfert RP, Gross ND, Lai SY, Gunn GB, Phan J, Rosenthal DI, Fuller CD, Morrison WH, Iyer P, Cabanillas ME.

Thyroid. 2019 Aug;29(8):1036-1043. doi: 10.1089/thy.2019.0133.

7.

Disruption of TP63-miR-27a* feedback loop by mutant TP53 in head and neck cancer.

Chari NS, Ivan C, Le X, Li J, Mijiti A, Patel AA, Osman AA, Peterson CB, Williams MD, Pickering CR, Caulin C, Myers JN, Calin GA, Lai SY.

J Natl Cancer Inst. 2019 May 24. pii: djz097. doi: 10.1093/jnci/djz097. [Epub ahead of print]

PMID:
31124563
8.

Incidental detection of oropharyngeal cancer with fluciclovine PET.

Jethanandani A, Chen MM, Gule-Monroe MK, Morrison WH, Lai SY, Johnson JM.

Head Neck. 2019 Aug;41(8):E141-E145. doi: 10.1002/hed.25798. Epub 2019 May 2.

PMID:
31046173
9.

Placental Origins of Preeclampsia: Potential Therapeutic Targets.

Wu JL, Jia J, He MZ, Zeng Y, Zhang JY, Shi EJ, Lai SY, Zhou X, Sharifu LM, Feng L.

Curr Med Sci. 2019 Apr;39(2):190-195. doi: 10.1007/s11596-019-2018-2. Epub 2019 Apr 23. Review.

PMID:
31016509
10.

Correction: Small-molecule inhibition of STAT3 in radioresistant head and neck squamous cell carcinoma.

Bharadwaj U, Eckols TK, Xu X, Kasembeli MM, Chen Y, Adachi M, Song Y, Mo Q, Lai SY, Tweardy DJ.

Oncotarget. 2019 Feb 22;10(16):1603. doi: 10.18632/oncotarget.26743. eCollection 2019 Feb 22.

11.

Surgical consensus guidelines on sentinel node biopsy (SNB) in patients with oral cancer.

Schilling C, Stoeckli SJ, Vigili MG, de Bree R, Lai SY, Alvarez J, Christensen A, Cognetti DM, D'Cruz AK, Frerich B, Garrel R, Kohno N, Klop WM, Kerawala C, Lawson G, McMahon J, Sassoon I, Shaw RJ, Tvedskov JF, von Buchwald C, McGurk M.

Head Neck. 2019 Aug;41(8):2655-2664. doi: 10.1002/hed.25739. Epub 2019 Mar 21.

PMID:
30896058
12.

Purification of lysozyme from chicken egg white using diatom frustules.

Guan YF, Lai SY, Lin CS, Suen SY, Wang MY.

Food Chem. 2019 Jul 15;286:483-490. doi: 10.1016/j.foodchem.2019.02.023. Epub 2019 Feb 14.

PMID:
30827636
13.

Identification of Neutralizing Monoclonal Antibodies Targeting Novel Conformational Epitopes of the Porcine Epidemic Diarrhoea Virus Spike Protein.

Chang CY, Cheng IC, Chang YC, Tsai PS, Lai SY, Huang YL, Jeng CR, Pang VF, Chang HW.

Sci Rep. 2019 Feb 21;9(1):2529. doi: 10.1038/s41598-019-39844-5.

14.

Outcomes of carotid-sparing IMRT for T1 glottic cancer: Comparison with conventional radiation.

Mohamed ASR, Smith BD, Smith JB, Sevak P, Malek JS, Kanwar A, Browne T, Gunn GB, Garden AS, Frank SJ, Morrison WH, Phan J, Zafereo M, Skinner H, Lai SY, Hutcheson KA, Lewin JS, Hessel AE, Thekdi AA, Weber RS, Fuller CD, Rosenthal DI.

Laryngoscope. 2019 Feb 12. doi: 10.1002/lary.27873. [Epub ahead of print]

PMID:
30756394
15.

Usefulness of surveillance imaging in patients with head and neck cancer who are treated with definitive radiotherapy.

Ng SP, Pollard C 3rd, Berends J, Ayoub Z, Kamal M, Garden AS, Bahig H, Cantor SB, Schaefer AJ, Ajayi T, Gunn GB, Frank SJ, Skinner H, Phan J, Morrison WH, Ferrarotto R, Johnson JM, Mohamed ASR, Lai SY, Hessel AC, Sturgis EM, Weber RS, Fuller CD, Rosenthal DI.

Cancer. 2019 Jun 1;125(11):1823-1829. doi: 10.1002/cncr.31983. Epub 2019 Feb 12.

PMID:
30748005
16.

Comprehensive Genetic Characterization of Human Thyroid Cancer Cell Lines: A Validated Panel for Preclinical Studies.

Landa I, Pozdeyev N, Korch C, Marlow LA, Smallridge RC, Copland JA, Henderson YC, Lai SY, Clayman GL, Onoda N, Tan AC, Garcia-Rendueles MER, Knauf JA, Haugen BR, Fagin JA, Schweppe RE.

Clin Cancer Res. 2019 May 15;25(10):3141-3151. doi: 10.1158/1078-0432.CCR-18-2953. Epub 2019 Feb 8.

PMID:
30737244
17.

Imaging-Genomic Study of Head and Neck Squamous Cell Carcinoma: Associations Between Radiomic Phenotypes and Genomic Mechanisms via Integration of The Cancer Genome Atlas and The Cancer Imaging Archive.

Zhu Y, Mohamed ASR, Lai SY, Yang S, Kanwar A, Wei L, Kamal M, Sengupta S, Elhalawani H, Skinner H, Mackin DS, Shiao J, Messer J, Wong A, Ding Y, Zhang L, Court L, Ji Y, Fuller CD.

JCO Clin Cancer Inform. 2019 Feb;3:1-9. doi: 10.1200/CCI.18.00073.

18.

Single-item discrimination of quality-of-life-altering dysphagia among 714 long-term oropharyngeal cancer survivors: Comparison of patient-reported outcome measures of swallowing.

MD Anderson Head and Neck Cancer Symptom Working Group, Grant S, Kamal M, Mohamed ASR, Zaveri J, Barrow MP, Gunn GB, Lai SY, Lewin JS, Rosenthal DI, Wang XS, Fuller CD, Hutcheson KA.

Cancer. 2019 May 15;125(10):1654-1664. doi: 10.1002/cncr.31957. Epub 2019 Jan 11.

PMID:
30633325
19.

Sex-Based Differences in Outcomes of Oral Anticoagulation: Does Antiplatelet Therapy Matter?

Mo FR, Yan YL, Li J, Lai SY.

J Am Coll Cardiol. 2018 Nov 13;72(20):2547. doi: 10.1016/j.jacc.2018.07.105. No abstract available.

PMID:
30442304
20.

Human papillomavirus 16 E7 oncoprotein alters the expression profiles of circular RNAs in Caski cells.

Zheng SR, Zhang HR, Zhang ZF, Lai SY, Huang LJ, Liu J, Bai X, Ding K, Zhou JY.

J Cancer. 2018 Sep 27;9(20):3755-3764. doi: 10.7150/jca.24253. eCollection 2018.

21.

Magnetic Resonance-based Response Assessment and Dose Adaptation in Human Papilloma Virus Positive Tumors of the Oropharynx treated with Radiotherapy (MR-ADAPTOR): An R-IDEAL stage 2a-2b/Bayesian phase II trial.

Bahig H, Yuan Y, Mohamed ASR, Brock KK, Ng SP, Wang J, Ding Y, Hutcheson K, McCulloch M, Balter PA, Lai SY, Al-Mamgani A, Sonke JJ, van der Heide UA, Nutting C, Li XA, Robbins J, Awan M, Karam I, Newbold K, Harrington K, Oelfke U, Bhide S, Philippens MEP, Terhaard CHJ, McPartlin AJ, Blanchard P, Garden AS, Rosenthal DI, Gunn GB, Phan J, Cazoulat G, Aristophanous M, McSpadden KK, Garcia JA, van den Berg CAT, Raaijmakers CPJ, Kerkmeijer L, Doornaert P, Blinde S, Frank SJ, Fuller CD.

Clin Transl Radiat Oncol. 2018 Aug 24;13:19-23. doi: 10.1016/j.ctro.2018.08.003. eCollection 2018 Nov.

22.

Publisher Correction: Neoadjuvant immune checkpoint blockade in high-risk resectable melanoma.

Amaria RN, Reddy SM, Tawbi HA, Davies MA, Ross MI, Glitza IC, Cormier JN, Lewis C, Hwu WJ, Hanna E, Diab A, Wong MK, Royal R, Gross N, Weber R, Lai SY, Ehlers R, Blando J, Milton DR, Woodman S, Kageyama R, Wells DK, Hwu P, Patel SP, Lucci A, Hessel A, Lee JE, Gershenwald J, Simpson L, Burton EM, Posada L, Haydu L, Wang L, Zhang S, Lazar AJ, Hudgens CW, Gopalakrishnan V, Reuben A, Andrews MC, Spencer CN, Prieto V, Sharma P, Allison J, Tetzlaff MT, Wargo JA.

Nat Med. 2018 Dec;24(12):1942. doi: 10.1038/s41591-018-0252-y.

PMID:
30361511
23.

Author Correction: Neoadjuvant immune checkpoint blockade in high-risk resectable melanoma.

Amaria RN, Reddy SM, Tawbi HA, Davies MA, Ross MI, Glitza IC, Cormier JN, Lewis C, Hwu WJ, Hanna E, Diab A, Wong MK, Royal R, Gross N, Weber R, Lai SY, Ehlers R, Blando J, Milton DR, Woodman S, Kageyama R, Wells DK, Hwu P, Patel SP, Lucci A, Hessel A, Lee JE, Gershenwald J, Simpson L, Burton EM, Posada L, Haydu L, Wang L, Zhang S, Lazar AJ, Hudgens CW, Gopalakrishnan V, Reuben A, Andrews MC, Spencer CN, Prieto V, Sharma P, Allison J, Tetzlaff MT, Wargo JA.

Nat Med. 2018 Dec;24(12):1941. doi: 10.1038/s41591-018-0251-z.

PMID:
30361510
24.

Sex-Based Differences in Outcomes of Coronary Stenting With Unprotected Left Main Disease.

Mo FR, Lai SY, Yan YL, Li J.

JACC Cardiovasc Interv. 2018 Oct 22;11(20):2125. doi: 10.1016/j.jcin.2018.07.053. No abstract available.

PMID:
30336818
25.

Neoadjuvant immune checkpoint blockade in high-risk resectable melanoma.

Amaria RN, Reddy SM, Tawbi HA, Davies MA, Ross MI, Glitza IC, Cormier JN, Lewis C, Hwu WJ, Hanna E, Diab A, Wong MK, Royal R, Gross N, Weber R, Lai SY, Ehlers R, Blando J, Milton DR, Woodman S, Kageyama R, Wells DK, Hwu P, Patel SP, Lucci A, Hessel A, Lee JE, Gershenwald J, Simpson L, Burton EM, Posada L, Haydu L, Wang L, Zhang S, Lazar AJ, Hudgens CW, Gopalakrishnan V, Reuben A, Andrews MC, Spencer CN, Prieto V, Sharma P, Allison J, Tetzlaff MT, Wargo JA.

Nat Med. 2018 Nov;24(11):1649-1654. doi: 10.1038/s41591-018-0197-1. Epub 2018 Oct 8. Erratum in: Nat Med. 2018 Oct 25;:. Nat Med. 2018 Oct 25;:.

26.

Predicting treatment Response based on Dual assessment of magnetic resonance Imaging kinetics and Circulating Tumor cells in patients with Head and Neck cancer (PREDICT-HN): matching 'liquid biopsy' and quantitative tumor modeling.

Ng SP, Bahig H, Wang J, Cardenas CE, Lucci A, Hall CS, Meas S, Sarli VN, Yuan Y, Urbauer DL, Ding Y, Ikner S, Dinh V, Elgohari BA, Johnson JM, Skinner HD, Gunn GB, Garden AS, Phan J, Rosenthal DI, Morrison WH, Frank SJ, Hutcheson KA, Mohamed ASR, Lai SY, Ferrarotto R, MacManus MP, Fuller CD.

BMC Cancer. 2018 Sep 19;18(1):903. doi: 10.1186/s12885-018-4808-5.

28.

Symptom Burden Associated With Late Lower Cranial Neuropathy in Long-term Oropharyngeal Cancer Survivors.

Aggarwal P, Zaveri JS, Goepfert RP, Shi Q, Du XL, Swartz M, Gunn GB, Lai SY, Fuller CD, Hanna EY, Rosenthal DI, Lewin JS, Piller LB, Hutcheson KA.

JAMA Otolaryngol Head Neck Surg. 2018 Nov 1;144(11):1066-1076. doi: 10.1001/jamaoto.2018.1791.

29.

Machine Learning Applications in Head and Neck Radiation Oncology: Lessons From Open-Source Radiomics Challenges.

Elhalawani H, Lin TA, Volpe S, Mohamed ASR, White AL, Zafereo J, Wong AJ, Berends JE, AboHashem S, Williams B, Aymard JM, Kanwar A, Perni S, Rock CD, Cooksey L, Campbell S, Yang P, Nguyen K, Ger RB, Cardenas CE, Fave XJ, Sansone C, Piantadosi G, Marrone S, Liu R, Huang C, Yu K, Li T, Yu Y, Zhang Y, Zhu H, Morris JS, Baladandayuthapani V, Shumway JW, Ghosh A, Pöhlmann A, Phoulady HA, Goyal V, Canahuate G, Marai GE, Vock D, Lai SY, Mackin DS, Court LE, Freymann J, Farahani K, Kaplathy-Cramer J, Fuller CD.

Front Oncol. 2018 Aug 17;8:294. doi: 10.3389/fonc.2018.00294. eCollection 2018.

30.

Self-reported oral morbidities in long-term oropharyngeal cancer survivors: A cross-sectional survey of 906 survivors.

MD Anderson Head and Neck Cancer Symptom Working Group.

Oral Oncol. 2018 Sep;84:88-94. doi: 10.1016/j.oraloncology.2018.07.006. Epub 2018 Jul 26.

PMID:
30115482
31.

Prospective in silico study of the feasibility and dosimetric advantages of MRI-guided dose adaptation for human papillomavirus positive oropharyngeal cancer patients compared with standard IMRT.

Mohamed ASR, Bahig H, Aristophanous M, Blanchard P, Kamal M, Ding Y, Cardenas CE, Brock KK, Lai SY, Hutcheson KA, Phan J, Wang J, Ibbott G, Gabr RE, Narayana PA, Garden AS, Rosenthal DI, Gunn GB, Fuller CD; MD Anderson MRLinac Development Working Group.

Clin Transl Radiat Oncol. 2018 May 5;11:11-18. doi: 10.1016/j.ctro.2018.04.005. eCollection 2018 Jun.

32.

Radiotherapy dose-volume parameters predict videofluoroscopy-detected dysphagia per DIGEST after IMRT for oropharyngeal cancer: Results of a prospective registry.

Kamal M, Mohamed ASR, Volpe S, Zaveri J, Barrow MP, Gunn GB, Lai SY, Ferrarotto R, Lewin JS, Rosenthal DI, Jethanandani A, Meheissen MAM, Mulder SL, Cardenas CE, Fuller CD, Hutcheson KA; MD Anderson Head, Neck Cancer Symptom Working Group.

Radiother Oncol. 2018 Sep;128(3):442-451. doi: 10.1016/j.radonc.2018.06.013. Epub 2018 Jun 28.

33.

Effect of Tumor Size and Minimal Extrathyroidal Extension in Patients with Differentiated Thyroid Cancer.

Tam S, Amit M, Boonsripitayanon M, Busaidy NL, Cabanillas ME, Waguespack SG, Gross ND, Grubbs EG, Williams MD, Lai SY, Sturgis EM, Zafereo ME.

Thyroid. 2018 Aug;28(8):982-990. doi: 10.1089/thy.2017.0513. Epub 2018 Jul 27.

PMID:
29936892
34.

Age-adjusted comorbidity and survival in locally advanced laryngeal cancer.

Multidisciplinary Larynx Cancer Working Group, Mulcahy CF, Mohamed ASR, Kanwar A, Hutcheson KA, Ghosh A, Vock D, Weber RS, Lai SY, Gunn GB, Zafereo M, Morrison WH, Ferrarotto R, Garden AS, Rosenthal DI, Fuller CD.

Head Neck. 2018 Sep;40(9):2060-2069. doi: 10.1002/hed.25200. Epub 2018 May 13.

35.

Incompletely treated malignancies of the major salivary gland: Toward evidence-based care.

Tam S, Sandulache VC, Metwalli KA, Rock CD, Eraj SA, Sheu T, El-Naggar AK, Fuller CD, Weber RS, Lai SY.

Head Neck. 2018 Aug;40(8):1630-1638. doi: 10.1002/hed.25156. Epub 2018 May 7.

PMID:
29734482
36.

Three-dimensional imaging assessment of anatomic invasion and volumetric considerations for chemo/radiotherapy-based laryngeal preservation in T3 larynx cancer.

Kamal M, Ng SP, Eraj SA, Rock CD, Pham B, Messer JA, Garden AS, Morrison WH, Phan J, Frank SJ, El-Naggar AK, Johnson JM, Ginsberg LE, Ferrarotto R, Lewin JS, Hutcheson KA, Cardenas CE, Zafereo ME, Lai SY, Hessel AC, Weber RS, Gunn GB, Fuller CD, Mohamed ASR, Rosenthal DI.

Oral Oncol. 2018 Apr;79:1-8. doi: 10.1016/j.oraloncology.2018.01.025. Epub 2018 Feb 10.

37.

Erratum: Dynamic contrast-enhanced magnetic resonance imaging for head and neck cancers.

Joint Head and Neck Radiotherapy-MRI Development Cooperative.

Sci Data. 2018 Mar 20;5:180041. doi: 10.1038/sdata.2018.41.

38.

Cisplatin generates oxidative stress which is accompanied by rapid shifts in central carbon metabolism.

Yu W, Chen Y, Dubrulle J, Stossi F, Putluri V, Sreekumar A, Putluri N, Baluya D, Lai SY, Sandulache VC.

Sci Rep. 2018 Mar 9;8(1):4306. doi: 10.1038/s41598-018-22640-y.

39.

Publisher Correction: A Multi-Institutional Comparison of Dynamic Contrast-Enhanced Magnetic Resonance Imaging Parameter Calculations.

Joint Head and Neck Radiotherapy-MRI Development Cooperative.

Sci Rep. 2018 Mar 8;8(1):4422. doi: 10.1038/s41598-018-20639-z.

40.

Niclosamide, an oral antihelmintic drug, exhibits antimetastatic activity in hepatocellular carcinoma cells through downregulating twist-mediated CD10 expression.

Chien MH, Ho YC, Yang SF, Yang YC, Lai SY, Chen WS, Chen MJ, Yeh CB.

Environ Toxicol. 2018 Jun;33(6):659-669. doi: 10.1002/tox.22551. Epub 2018 Feb 26.

PMID:
29480568
41.

Dynamic contrast-enhanced magnetic resonance imaging for head and neck cancers.

Joint Head and Neck Radiotherapy-MRI Development Cooperative.

Sci Data. 2018 Feb 13;5:180008. doi: 10.1038/sdata.2018.8. Erratum in: Sci Data. 2018 Mar 20;5:180041.

42.

Myosin 1b promotes cell proliferation, migration, and invasion in cervical cancer.

Zhang HR, Lai SY, Huang LJ, Zhang ZF, Liu J, Zheng SR, Ding K, Bai X, Zhou JY.

Gynecol Oncol. 2018 Apr;149(1):188-197. doi: 10.1016/j.ygyno.2018.01.024. Epub 2018 Feb 1.

PMID:
29395313
43.

Investigation of radiomic signatures for local recurrence using primary tumor texture analysis in oropharyngeal head and neck cancer patients.

M. D. Anderson Cancer Center Head and Neck Quantitative Imaging Working Group.

Sci Rep. 2018 Jan 24;8(1):1524. doi: 10.1038/s41598-017-14687-0.

44.

High expression of TMEM40 is associated with the malignant behavior and tumorigenesis in bladder cancer.

Zhang ZF, Zhang HR, Zhang QY, Lai SY, Feng YZ, Zhou Y, Zheng SR, Shi R, Zhou JY.

J Transl Med. 2018 Jan 19;16(1):9. doi: 10.1186/s12967-017-1377-3.

45.

Association of Lymph Node Density With Survival of Patients With Papillary Thyroid Cancer.

Amit M, Tam S, Boonsripitayanon M, Cabanillas ME, Busaidy NL, Grubbs EG, Lai SY, Gross ND, Sturgis EM, Zafereo ME.

JAMA Otolaryngol Head Neck Surg. 2018 Feb 1;144(2):108-114. doi: 10.1001/jamaoto.2017.2416. Erratum in: JAMA Otolaryngol Head Neck Surg. 2019 May 1;145(5):484.

46.

Correction to: Long-term patient reported outcomes following radiation therapy for oropharyngeal cancer: cross-sectional assessment of a prospective symptom survey in patients ≥65 years old.

MD Anderson Head and Neck Cancer Symptom Working Group, Eraj SA, Jomaa MK, Rock CD, Mohamed ASR, Smith BD, Smith JB, Browne T, Cooksey LC, Williams B, Temple B, Preston KE, Aymard JM, Gross ND, Weber RS, Hessel AC, Ferrarotto R, Phan J, Sturgis EM, Hanna EY, Frank SJ, Morrison WH, Goepfert RP, Lai SY, Rosenthal DI, Mendoza TR, Cleeland CS, Hutcheson KA, Fuller CD, Garden AS, Brandon Gunn G.

Radiat Oncol. 2017 Nov 23;12(1):186. doi: 10.1186/s13014-017-0921-x.

47.

Cough strength and expiratory force in aspirating and nonaspirating postradiation head and neck cancer survivors.

Hutcheson KA, Barrow MP, Warneke CL, Wang Y, Eapen G, Lai SY, Barringer DA, Plowman EK, Lewin JS.

Laryngoscope. 2018 Jul;128(7):1615-1621. doi: 10.1002/lary.26986. Epub 2017 Nov 8.

48.

Adjuvant External Beam Radiotherapy in Locally Advanced Differentiated Thyroid Cancer.

Tam S, Amit M, Boonsripitayanon M, Cabanillas ME, Busaidy NL, Gunn GB, Lai SY, Gross ND, Sturgis EM, Zafereo ME.

JAMA Otolaryngol Head Neck Surg. 2017 Dec 1;143(12):1244-1251. doi: 10.1001/jamaoto.2017.2077. No abstract available.

49.

Influence of parameter accuracy on pharmacokinetic analysis of hyperpolarized pyruvate.

Sun CY, Walker CM, Michel KA, Venkatesan AM, Lai SY, Bankson JA.

Magn Reson Med. 2018 Jun;79(6):3239-3248. doi: 10.1002/mrm.26992. Epub 2017 Nov 1.

50.

Management of the lateral neck compartment in patients with sporadic medullary thyroid cancer.

Pena I, Clayman GL, Grubbs EG, Bergeron JM Jr, Waguespack SG, Cabanillas ME, Dadu R, Hu MI, Fellman BM, Li Y, Gross ND, Lai SY, Sturgis EM, Zafereo ME.

Head Neck. 2018 Jan;40(1):79-85. doi: 10.1002/hed.24969. Epub 2017 Oct 16.

PMID:
29044788

Supplemental Content

Loading ...
Support Center